Mar 2, 2023 | Press Releases, Publication
DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) — Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal (GI) cancers, announced that the U.S. Patent and Trademark Office has issued new patent No. 11,583,576,...
Jan 19, 2022 | Press Releases, Publication
DURHAM, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) — Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, will host a virtual presentation of its poster at the American Society of Clinical Oncology’s...
Dec 6, 2021 | Press Releases, Publication
DURHAM, N.C., Dec. 06, 2021 (GLOBE NEWSWIRE) — Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces a new publication in Frontiers in Oncology, section Gastrointestinal Cancers: Gastric...
Aug 30, 2021 | Press Releases, Publication
Jill P. Smith1, Hong Cao1, Wenqiang Chen1, Bhaskar Kallakury2, Teresa Phillips3, Lynda Sutton3,and Allen Cato3 ABSTRACT The incidence of pancreatic cancer is increasing significantly and will soon become the second leading cause of cancer-related deaths in the...
Aug 18, 2021 | media-presentation
About Cancer Advances, Inc. Cancer Advances Inc. (Durham, NC) is a biotechnology company focused on impacting human health and preventing the progression of gastrointestinal cancers by enhancing the adaptive immune system. The company is led by an experienced...
Recent Comments